In this study, we further observed a positive correlation between SRGN and CD44 expression in malignant cells at both single-cell and bulk transcriptome levels (Supplementary Figure 8A, B) and in HCC cell lines (Figure 7B). Here, CD44 is linked to hepatocellular carcinoma.